Yilmaz, N. (2020) “HIGH MOBILITY GROUP BOX-1 LEVELS IN SCHIZOPHRENIA: POTENTIAL BIOMARKER OF REMISSION PHASE : High mobility group box-1 levels in Schizophrenia”, Journal of Medical Biochemistry, 40(3), pp. 295–301. doi:10.5937/jomb0-28108.